Literature DB >> 17299845

Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis.

Patrick H Dessein1, Gavin R Norton, Angela J Woodiwiss, Barry I Joffe, Ahmed Solomon.   

Abstract

OBJECTIVE: We elucidated whether factors that determine systemic inflammation in the general population independently contribute to C-reactive protein (CRP) concentrations in rheumatoid arthritis (RA).
METHODS: The association between factors known to be associated with systemic inflammation in the general population (age, sex, lifestyle variables, metabolic syndrome features, and estrogen use) and high sensitivity CRP (hs-CRP) concentrations independent of the Disease Activity Score 28 (DAS28) was determined in 94 patients with RA.
RESULTS: In all patients, the DAS28 (p < 0.0001), ever smoking (p <or= 0.006), waist circumference (p = 0.03), and the homeostasis model assessment of insulin resistance (HOMA-IR; p = 0.03) were independently associated with hs-CRP. Although in patients without central obesity (n = 53, 56%), the DAS28 was the only independent predictor of inflammation and contributed 28%-30% to the variability of hs-CRP, in patients with National Cholesterol Education Program (NCEP) defined central obesity (n = 41, 44%), smoking contributed 13%, the HOMA-IR 21%, and the DAS28 21% to the variability of hs-CRP. In centrally obese patients, the standardized regression coefficient for the independent relationship between HOMA-IR and hs-CRP (0.401 +/- 0.132) was similar to that for DAS28 and hs-CRP (0.432 +/- 0.144); and the HOMA-IR (p = 0.04) was associated with hs-CRP independent of waist circumference.
CONCLUSION: In patients with RA with NCEP-defined central obesity, insulin resistance explains a degree of the variability of CRP concentrations equivalent to that of disease activity. These findings have potential implications for the use of CRP as an RA disease activity marker, and in understanding the reported relationship of CRP with cardiovascular disease in RA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299845

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

Review 1.  Rheumatoid cachexia and cardiovascular disease.

Authors:  Gregory D Summers; Giorgos S Metsios; Antonios Stavropoulos-Kalinoglou; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2010-07-20       Impact factor: 20.543

Review 2.  Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps.

Authors:  Thomas Zegkos; George Kitas; Theodoros Dimitroulas
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-04-30       Impact factor: 5.346

3.  Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study.

Authors:  D Jawaheer; J Olsen; M Lahiff; S Forsberg; J Lähteenmäki; I G da Silveira; F A Rocha; I M Magalhães Laurindo; L M Henrique da Mota; A A Drosos; E Murphy; C Sheehy; E Quirke; M Cutolo; S Rexhepi; J Dadoniene; S M M Verstappen; T Sokka
Journal:  Clin Exp Rheumatol       Date:  2010-08-30       Impact factor: 4.473

Review 4.  Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.

Authors:  Deborah P M Symmons; Sherine E Gabriel
Journal:  Nat Rev Rheumatol       Date:  2011-05-31       Impact factor: 20.543

5.  Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis.

Authors:  Michael D George; Jon T Giles; Patricia P Katz; Bryant R England; Ted R Mikuls; Kaleb Michaud; Alexis R Ogdie-Beatty; Said Ibrahim; Grant W Cannon; Liron Caplan; Brian C Sauer; Joshua F Baker
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-11-06       Impact factor: 4.794

Review 6.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

7.  Association of body fat with C-reactive protein in rheumatoid arthritis.

Authors:  Jon T Giles; Susan J Bartlett; Ross Andersen; Richard Thompson; Kevin R Fontaine; Joan M Bathon
Journal:  Arthritis Rheum       Date:  2008-09

Review 8.  Metabolic syndrome in rheumatoid arthritis.

Authors:  Iván Ferraz-Amaro; Carlos González-Juanatey; Raquel López-Mejias; Leyre Riancho-Zarrabeitia; Miguel A González-Gay
Journal:  Mediators Inflamm       Date:  2013-01-30       Impact factor: 4.711

Review 9.  Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

Authors:  Agata N Burska; Rajalingham Sakthiswary; Naveed Sattar
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

10.  Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study.

Authors:  Patrick H Dessein; Angela J Woodiwiss; Gavin R Norton; Ahmed Solomon
Journal:  Arthritis Res Ther       Date:  2013-08-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.